Recent innovations in diabetes treatment, including new devices and medications, have improved care and survival. However, disparities in the availability of these treatments to racial and ethnic minorities may contribute to continued inequities in CVD outcomes. Racial/ethnic disparities in CVD relate to inequities in economic opportunity, education and health literacy, neighborhoods and social cohesion, and health care access and quality driven by structural racism.
Keyphrases
- healthcare
- affordable care act
- type diabetes
- glycemic control
- cardiovascular disease
- quality improvement
- health information
- mental health
- palliative care
- risk factors
- health insurance
- free survival
- insulin resistance
- social media
- combination therapy
- adipose tissue
- metabolic syndrome
- african american
- chronic pain
- life cycle